NO20050929L - Fremgangsmater for fremstilling, isolering og rensing av epotilon B og rontgen krystallstrukturer av eptilon B - Google Patents

Fremgangsmater for fremstilling, isolering og rensing av epotilon B og rontgen krystallstrukturer av eptilon B

Info

Publication number
NO20050929L
NO20050929L NO20050929A NO20050929A NO20050929L NO 20050929 L NO20050929 L NO 20050929L NO 20050929 A NO20050929 A NO 20050929A NO 20050929 A NO20050929 A NO 20050929A NO 20050929 L NO20050929 L NO 20050929L
Authority
NO
Norway
Prior art keywords
isolation
purification
eptilon
epotilon
preparation
Prior art date
Application number
NO20050929A
Other languages
English (en)
Other versions
NO334167B1 (no
Inventor
Daniel Benigni
Robert Stankavage
Shu-Jen Chiang
Hsing Hou
Bruce Eagan
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20050929L publication Critical patent/NO20050929L/no
Publication of NO334167B1 publication Critical patent/NO334167B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse vedrører forbedrede fremgangsmåter for produksjon, isolasjon og rensing av epotilon B. Disse fremgangsmåtene innbefatter for eksempel en fermenteringsprosess for produksjon av epotilon B, isolering via adsorpsjon til en harpiks, og påfølgende rensing.
NO20050929A 2002-09-23 2005-02-21 Fremgangsmåter for isolering og rensing av epotilon B. NO334167B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41299402P 2002-09-23 2002-09-23
PCT/US2003/029628 WO2004026254A2 (en) 2002-09-23 2003-09-22 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b

Publications (2)

Publication Number Publication Date
NO20050929L true NO20050929L (no) 2005-04-08
NO334167B1 NO334167B1 (no) 2013-12-23

Family

ID=32030950

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050929A NO334167B1 (no) 2002-09-23 2005-02-21 Fremgangsmåter for isolering og rensing av epotilon B.

Country Status (23)

Country Link
US (4) US7172884B2 (no)
EP (3) EP1542998A4 (no)
JP (2) JP4523843B2 (no)
KR (2) KR20050053681A (no)
CN (2) CN1705662B (no)
AU (1) AU2003275068B2 (no)
BR (1) BRPI0314133A8 (no)
CA (3) CA2499600C (no)
CO (1) CO5540384A2 (no)
ES (2) ES2405753T3 (no)
GE (1) GEP20074017B (no)
HK (1) HK1113387A1 (no)
HR (1) HRP20050278A2 (no)
IL (2) IL166868A (no)
IS (1) IS7768A (no)
MX (1) MXPA05003006A (no)
NO (1) NO334167B1 (no)
PL (1) PL375902A1 (no)
RS (1) RS20050235A (no)
RU (1) RU2368661C2 (no)
TW (1) TWI291464B (no)
WO (1) WO2004026254A2 (no)
ZA (1) ZA200501680B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2198173C2 (ru) * 1996-11-18 2003-02-10 Гезелльшафт Фюр Биотехнологише Форшунг Мбх (Гбф) Эпотилоны c, d, e и f, их получение и средства на их основе
EP0977563B1 (en) 1996-12-03 2005-10-12 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6780620B1 (en) 1998-12-23 2004-08-24 Bristol-Myers Squibb Company Microbial transformation method for the preparation of an epothilone
US6518421B1 (en) 2000-03-20 2003-02-11 Bristol-Myers Squibb Company Process for the preparation of epothilone analogs
WO2002066038A1 (en) 2001-02-20 2002-08-29 Bristol-Myers Squibb Company Treatment of refractory tumors using epothilone derivatives
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
EP1767535B1 (en) 2002-08-23 2009-12-02 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US7172884B2 (en) * 2002-09-23 2007-02-06 Bristol-Myers Squibb Company Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B
US20050171167A1 (en) * 2003-11-04 2005-08-04 Haby Thomas A. Process and formulation containing epothilones and analogs thereof
US20090004277A1 (en) * 2004-05-18 2009-01-01 Franchini Miriam K Nanoparticle dispersion containing lactam compound
EP1856255A4 (en) 2005-02-11 2010-01-27 Univ Southern California METHODS OF EXPRESSING PROTEINS WITH DISULFIDE BRIDGES
AU2007238307B2 (en) * 2006-04-05 2011-06-09 Novartis Ag Combinations of therapeutic agents for treating cancer
WO2007130501A2 (en) * 2006-05-01 2007-11-15 University Of Southern California Combination therapy for treatment of cancer
CN101506217B (zh) * 2006-08-16 2012-09-05 诺瓦提斯公司 埃坡霉素b的晶型及在药物组合物中的用途
JP5180321B2 (ja) * 2008-02-01 2013-04-10 浙江海正薬業股▲ふん▼有限公司 エポチロンの分離及び精製方法
DK2276485T3 (da) 2008-04-24 2014-10-13 Bristol Myers Squibb Co Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
KR101372563B1 (ko) * 2011-12-26 2014-03-14 주식회사 삼양바이오팜 에포틸론 함유물질로부터 에포틸론 ａ와 ｂ의 추출 및 정제 방법
CN103183681B (zh) * 2013-03-06 2016-01-13 浙江海正药业股份有限公司 伊沙匹隆的新晶型及其制备方法
WO2015024883A1 (en) * 2013-08-19 2015-02-26 Sandoz Ag Method for the purification of epothilones via crystallization
EP3036240A1 (en) * 2013-08-19 2016-06-29 Sandoz AG Method for the purifiction of epothilones via crystallization
CN104046579B (zh) * 2014-05-16 2016-09-21 虞龙 一株埃博霉素高产菌及其在发酵产埃博霉素中的应用
CN106834377B (zh) * 2017-03-07 2020-05-05 鲁南制药集团股份有限公司 一种生产埃博霉素b的方法
CN106905338B (zh) * 2017-03-07 2020-06-23 鲁南制药集团股份有限公司 一种埃博霉素b的提纯方法
CN107827943B (zh) * 2017-11-28 2022-06-10 绍兴厚普生物科技有限责任公司 一种从发酵液中提取胞嘧啶核苷的方法
CN110964029B (zh) * 2019-12-19 2020-11-03 鲁南制药集团股份有限公司 一种埃博霉素b发酵液的预处理方法
KR102440644B1 (ko) * 2020-05-28 2022-09-05 공주대학교 산학협력단 파클리탁셀 정제 시 가스 버블을 이용한 분별침전방법
CN112409369B (zh) * 2020-11-30 2023-03-28 湖北宏中药业股份有限公司 一种埃博霉素b的高效提取纯化方法
CN112457320A (zh) * 2020-11-30 2021-03-09 湖北宏中药业股份有限公司 一种提高伊沙匹隆合成反应速率的方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE879605C (de) 1951-08-05 1953-06-15 Leitz Ernst Gmbh Optisches Instrument mit gekuppeltem Objektiv- und Kondensor-Wechsler
DE3669515D1 (de) * 1985-09-13 1990-04-19 Biotechnolog Forschung Gmbh Makrozyklische antibiotika.
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
DE19639456A1 (de) 1996-09-25 1998-03-26 Biotechnolog Forschung Gmbh Epothilon-Derivate, Herstellung und Mittel
DE19542986A1 (de) 1995-11-17 1997-05-22 Biotechnolog Forschung Gmbh Epothilon-Derivate und deren Verwendung
ATE249463T1 (de) * 1995-11-17 2003-09-15 Biotechnolog Forschung Gmbh Epothilonderivate, herstellung und verwendung
DE19645361A1 (de) 1996-08-30 1998-04-30 Ciba Geigy Ag Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II
DE19645362A1 (de) 1996-10-28 1998-04-30 Ciba Geigy Ag Verfahren zur Herstellung von Epothilon A und B und Derivaten
DE19636343C1 (de) 1996-08-30 1997-10-23 Schering Ag Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B
WO1998008849A1 (de) 1996-08-30 1998-03-05 Novartis Aktiengesellschaft Verfahren zur herstellung von epothilonen und zwischenprodukte innerhalb des verfahrens
RU2198173C2 (ru) * 1996-11-18 2003-02-10 Гезелльшафт Фюр Биотехнологише Форшунг Мбх (Гбф) Эпотилоны c, d, e и f, их получение и средства на их основе
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
EP0977563B1 (en) * 1996-12-03 2005-10-12 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6204388B1 (en) * 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6441186B1 (en) 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
US6380394B1 (en) 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
DE19701758A1 (de) 1997-01-20 1998-07-23 Wessjohann Ludgar A Dr Epothilone-Synthesebausteine
EP1201666A3 (de) 1997-02-25 2003-03-05 Gesellschaft für biotechnologische Forschung mbH (GBF) Seitenkettenmodifizierte Epothilone
DE19713970B4 (de) 1997-04-04 2006-08-31 R&D-Biopharmaceuticals Gmbh Epothilone-Synthesebausteine II - Prenylderivate
JP4065573B2 (ja) 1997-04-18 2008-03-26 ベーリンガー・インゲルハイム・インテルナツィオナール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 反応媒体として圧縮二酸化炭素中における二官能性または多官能性基質の選択的オレフィンメタセシス
DE19720312A1 (de) 1997-05-15 1998-11-19 Hoechst Ag Zubereitung mit erhöhter in vivo Verträglichkeit
DE19821954A1 (de) 1997-05-15 1998-11-19 Biotechnolog Forschung Gmbh Verfahren zur Herstellung eines Epothilon-Derivats
DE19726627A1 (de) 1997-06-17 1998-12-24 Schering Ag Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Epothilon
US6605599B1 (en) 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
PT1001951E (pt) 1997-07-16 2003-02-28 Schering Ag Derivados de tiazolo, processo para a sua preparacao e utilizacao
ES2290993T3 (es) 1997-08-09 2008-02-16 Bayer Schering Pharma Aktiengesellschaft Nuevos derivados de epotilona, proceso para su produccion y su utilizacion farmaceutica.
US6365749B1 (en) 1997-12-04 2002-04-02 Bristol-Myers Squibb Company Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
US6320045B1 (en) * 1997-12-04 2001-11-20 Bristol-Myers Squibb Company Process for the reduction of oxiranyl epothilones to olefinic epothilones
MY125921A (en) 1998-02-05 2006-08-30 Novartis Ag Compositions containing organic compounds
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
WO1999043653A1 (en) 1998-02-25 1999-09-02 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues therof
FR2775187B1 (fr) 1998-02-25 2003-02-21 Novartis Ag Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
FR2776071B1 (fr) * 1998-03-13 2000-05-26 Eastman Kodak Co Dispositif de mesure automatique de la concentration d'un agent developpateur
US6399638B1 (en) 1998-04-21 2002-06-04 Bristol-Myers Squibb Company 12,13-modified epothilone derivatives
WO2000000485A1 (de) 1998-06-30 2000-01-06 Schering Aktiengesellschaft Epothilon-derivate, verfahren zu deren herstellung, zwischenprodukte und ihre pharmazeutische verwendung
US6303342B1 (en) 1998-11-20 2001-10-16 Kason Biosciences, Inc. Recombinant methods and materials for producing epothilones C and D
DE69910831T2 (de) 1998-12-22 2004-07-15 Novartis Ag Epothilonderivate und ihre verwendung als antitumormittel
AU754459B2 (en) 1998-12-23 2002-11-14 Bristol-Myers Squibb Company Microbial transformation method for the preparation of an epothilone
EP1150980B1 (de) 1999-02-18 2007-08-22 Bayer Schering Pharma Aktiengesellschaft 16-halogen-epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
DE60006649T2 (de) 1999-02-22 2004-09-30 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) C-21 modifizierte epothilone
US6211412B1 (en) * 1999-03-29 2001-04-03 The University Of Kansas Synthesis of epothilones
AR023792A1 (es) 1999-04-30 2002-09-04 Bayer Schering Pharma Ag Derivados 6-alquenilo- y 6-alquinilo-epotilona, los procedimientos para prepararlos y su empleo en productos farmaceuticos
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds
CN1142163C (zh) * 2002-02-07 2004-03-17 山东大学 一种从粘细菌发酵液中分离提纯埃博霉素的方法
TW200303202A (en) 2002-02-15 2003-09-01 Bristol Myers Squibb Co Method of preparation of 21-amino epothilone derivatives
US7172884B2 (en) * 2002-09-23 2007-02-06 Bristol-Myers Squibb Company Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B

Also Published As

Publication number Publication date
US7241899B2 (en) 2007-07-10
IL166868A (en) 2012-12-31
EP1542998A2 (en) 2005-06-22
EP1542998A4 (en) 2007-01-31
RS20050235A (en) 2007-06-04
EP2287168A3 (en) 2011-03-16
HK1113387A1 (en) 2008-10-03
TWI291464B (en) 2007-12-21
US7767432B2 (en) 2010-08-03
AU2003275068B2 (en) 2009-09-17
WO2004026254A2 (en) 2004-04-01
ES2405753T3 (es) 2013-06-03
CN101050445B (zh) 2011-08-10
KR20050053681A (ko) 2005-06-08
EP2280014B1 (en) 2013-10-23
ES2439995T3 (es) 2014-01-27
GEP20074017B (en) 2007-01-10
CN1705662A (zh) 2005-12-07
CN101050445A (zh) 2007-10-10
US20060135474A1 (en) 2006-06-22
EP2280014A2 (en) 2011-02-02
CA2695720C (en) 2013-04-02
BRPI0314133A8 (pt) 2017-09-19
IL222455A0 (en) 2012-12-02
EP2280014A3 (en) 2011-08-03
WO2004026254A3 (en) 2004-05-27
IS7768A (is) 2005-03-22
HRP20050278A2 (en) 2005-10-31
PL375902A1 (en) 2005-12-12
CA2695671A1 (en) 2004-04-01
MXPA05003006A (es) 2005-06-22
KR20120080649A (ko) 2012-07-17
TW200409773A (en) 2004-06-16
JP2006500031A (ja) 2006-01-05
RU2368661C2 (ru) 2009-09-27
ZA200501680B (en) 2006-05-31
CO5540384A2 (es) 2005-07-29
JP4523843B2 (ja) 2010-08-11
EP2287168A2 (en) 2011-02-23
EP2287168B1 (en) 2013-02-13
CN1705662B (zh) 2011-07-06
US20040132146A1 (en) 2004-07-08
CA2499600A1 (en) 2004-04-01
AU2003275068A1 (en) 2004-04-08
BR0314133A (pt) 2005-07-12
NO334167B1 (no) 2013-12-23
US7172884B2 (en) 2007-02-06
JP2010011873A (ja) 2010-01-21
JP5193983B2 (ja) 2013-05-08
CA2499600C (en) 2012-08-21
CA2695720A1 (en) 2004-04-01
USRE42191E1 (en) 2011-03-01
RU2005112443A (ru) 2005-10-27
KR101406635B1 (ko) 2014-06-11
US20070122891A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
NO20050929L (no) Fremgangsmater for fremstilling, isolering og rensing av epotilon B og rontgen krystallstrukturer av eptilon B
NO20074222L (no) Fremgangsmater for fremstilling av ansamitosiner
NO20074102L (no) Rensing av Rapamycin
NO20071943L (no) Systemer og fremgangsmater for lavtemperatursgasseparasjon
NO20034366L (no) Apparatur og produksjonsmetode for produksjon av hydrogen med höyt trykk
WO2002103008A3 (en) Templated molecules and methods for using such molecules
WO2006010663A3 (de) Verfahren zur versiegelung von natursteinen
ATE415402T1 (de) Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen
NO20072661L (no) Rensing av glykopeptider
MY148297A (en) Process for modifying drug crystal formation
NO20072290L (no) Organiske forbindelser.
WO2006130786A3 (en) Water treatment system and process
RS20060297A (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
NO20074215L (no) Fremgangsmate for reduksjon og/eller rensing av metallholdig slagg
MY128409A (en) Process for the isolation and purification of epothilones
NO20030647D0 (no) Fremgangsmåte og anlegg for rensing av produsert vann
NO20043598L (no) Fremgangsmate og anlegg for biologisk behandling av vannholdige utslipp for rensing av samme
WO2004005920A3 (de) Verfahren zur anreicherung und zum nachweis von pathologisch veränderten prion-proteinen (prpsc)
IL158400A0 (en) Process for the production of citalopram
ATE437178T1 (de) Analgetisches antitumorpeptid aus skorpionen und verfahren zu dessen herstellung
AU2003283305A1 (en) Compounds which can be activated by actinic radiation and contain urethane groups, method for the production thereof and use of the same
EA200500329A1 (ru) Способ получения глюкозы из целлюлозосодержащего сырья, преимущественно отходов пивного производства
SE0201207D0 (sv) A process for production of a regioselective membrane
AU2002358557A1 (en) Improved method for the production of biphosphites

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees